Literature DB >> 2508944

Smoking and occupational allergy in workers in a platinum refinery.

K M Venables1, M B Dally, A J Nunn, J F Stevens, R Stephens, N Farrer, J V Hunter, M Stewart, E G Hughes, A J Newman Taylor.   

Abstract

OBJECTIVE: To test the hypothesis that smoking increases the risk of sensitisation by occupational allergens.
DESIGN: Historical prospective cohort study.
SETTING: Platinum refinery.
SUBJECTS: 91 Workers (86 men) who started work between 1 January 1973 and 31 December 1974 and whose smoking habit and atopic state (on skin prick testing with common allergens) had been noted at joining. MAIN OUTCOME MEASURES: Results of skin prick tests with platinum salts carried out routinely every three to six months and records of any respiratory symptoms noted by the refinery's occupational health service. Follow up was until 1980 or until leaving refinery work, whichever was earlier.
RESULTS: 57 Workers smoked and 29 were atopic; 22 developed a positive result on skin testing with platinum salts and 49 developed symptoms, including all 22 whose skin test result was positive. Smoking was the only significant predictor of a positive result on skin testing with platinum salts and its effect was greater than that of atopy; the estimated relative risks (95% confidence interval) when both were included in the regression model were: smokers versus non-smokers 5.05 (1.68 to 15.2) and atopic versus non-atopic 2.29 (0.88 to 5.99). Number of cigarettes smoked per day was the only significant predictor of respiratory symptoms.
CONCLUSION: Smokers are at increased risk of sensitisation by platinum salts.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508944      PMCID: PMC1837835          DOI: 10.1136/bmj.299.6705.939

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  10 in total

1.  Immediate (type I) allergic responses to platinum compounds.

Authors:  M J Cleare; E G Hughes; B Jacoby; J Pepys
Journal:  Clin Allergy       Date:  1976-03

2.  Association of asthma with serum IgE levels and skin-test reactivity to allergens.

Authors:  B Burrows; F D Martinez; M Halonen; R A Barbee; M G Cline
Journal:  N Engl J Med       Date:  1989-02-02       Impact factor: 91.245

3.  Another smoking hazard: raised serum IgE concentration and increased risk of occupational allergy.

Authors:  O Zetterström; K Osterman; L Machado; S G Johansson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-07

4.  Interaction of smoking and atopy in producing specific IgE antibody against a hapten protein conjugate.

Authors:  K M Venables; M D Topping; W Howe; C M Luczynska; R Hawkins; A J Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-19

5.  Medical surveillance of platinum refinery workers.

Authors:  E G Hughes
Journal:  J Soc Occup Med       Date:  1980-01

6.  Asthma due to inhaled chemical agents--complex salts of platinum.

Authors:  J Pepys; C A Pickering; E G Hughes
Journal:  Clin Allergy       Date:  1972-12

7.  Ozone enhancement of platinum asthma in a primate model.

Authors:  R E Biagini; W J Moorman; T R Lewis; I L Bernstein
Journal:  Am Rev Respir Dis       Date:  1986-10

8.  Increased IgE antibody responses in rats exposed to tobacco smoke.

Authors:  O Zetterström; S L Nordvall; B Björkstén; S Ahlstedt; M Stelander
Journal:  J Allergy Clin Immunol       Date:  1985-05       Impact factor: 10.793

9.  Passive transfer in man and the monkey of Type I allergy due to heat labile and heat stable antibody to complex salts of platinum.

Authors:  J Pepys; W E Parish; O Cromwell; E G Hughes
Journal:  Clin Allergy       Date:  1979-03

10.  Occupational asthma in snow crab-processing workers.

Authors:  A Cartier; J L Malo; F Forest; M Lafrance; L Pineau; J J St-Aubin; J Y Dubois
Journal:  J Allergy Clin Immunol       Date:  1984-09       Impact factor: 10.793

  10 in total
  19 in total

1.  Follow up investigation of workers in synthetic fibre plants with humidifier disease and work related asthma.

Authors:  T M Pal; J G de Monchy; J W Groothoff; D Post
Journal:  Occup Environ Med       Date:  1999-06       Impact factor: 4.402

2.  Occupational asthma due to chrome and nickel electroplating.

Authors:  P Bright; P S Burge; S P O'Hickey; P F Gannon; A S Robertson; A Boran
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

Review 3.  Comparison of soybean epidemic asthma and occupational asthma.

Authors:  J M Antó; J Sunyer; A J Newman Taylor
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

4.  Risk factors for sensitisation and respiratory symptoms among workers exposed to acid anhydrides: a cohort study.

Authors:  R D Barker; M J van Tongeren; J M Harris; K Gardiner; K M Venables; A J Newman Taylor
Journal:  Occup Environ Med       Date:  1998-10       Impact factor: 4.402

5.  Serial measurements of peak expiratory flow and responsiveness to methacholine in the diagnosis of aluminium potroom asthma.

Authors:  J Kongerud; V Søyseth; S Burge
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

Review 6.  Evidence based guidelines for the prevention, identification, and management of occupational asthma.

Authors:  P J Nicholson; P Cullinan; A J Newman Taylor; P S Burge; C Boyle
Journal:  Occup Environ Med       Date:  2005-05       Impact factor: 4.402

7.  Asthma outbreaks: an opportunity for research?

Authors:  J M Anto
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139

8.  The IgE and IgG antibody responses to aerosols of Nephrops norvegicus (prawn) antigens: the association with clinical hypersensitivity and with cigarette smoking.

Authors:  C McSharry; K Anderson; I C McKay; M J Colloff; C Feyerabend; R B Wilson; P C Wilkinson
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

9.  Asthma in children: environmental factors.

Authors:  P Cullinan; A J Taylor
Journal:  BMJ       Date:  1994-06-18

10.  20 years of medical surveillance on exposure to allergenic and non-allergenic platinum compounds: the importance of chemical speciation.

Authors:  P J Linnett; E G Hughes
Journal:  Occup Environ Med       Date:  1999-03       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.